Tasly Pharmaceutical Group Co., Ltd (600535.SS)

13.24 +0.23 (+1.77%) As of 01:21PM CST. Market open.

Tasly Pharmaceutical Group Co., Ltd

No. 2, Puji East Road
Beichen District
Tianjin 300410
China
86 22 2673 6999
https://www.taslypharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 9,223

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jing Su	GM & Director	N/A	N/A	1963
Ms. Jie Wei	CFO & Head of Accounting	N/A	N/A	1977
Mr. Yu Jie	Secretary & VP	N/A	N/A	1975
Mr. Jin Yong Cai	Deputy GM & Employee Representative of the Supervisory Board	N/A	N/A	1973
Mr. Hongwei Liu	Deputy GM & Vice Chairman of the Supervisory Board	N/A	N/A	1971
Mr. Shunnan Zhang	Deputy GM & Supervisor	N/A	N/A	1973

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China.

Corporate governance

Tasly Pharmaceutical Group Co., Ltd’s ISS governance QualityScore as of 1 June 2024 is 6. The pillar scores are Audit: 7; Board: 9; Shareholder rights: 2; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.